Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM3VNK0)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Sphingosine-1-phosphate receptor 3 (S1PR3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
US9522888, 575	DM6UXZK	N. A.	N. A.	Patented	[2]
US9617250, Example 1 Example 204 of D1	DM89LKQ	N. A.	N. A.	Patented	[1]
YYDJCLCSBYCSCO-UHFFFAOYSA-N	DMA91FM	N. A.	N. A.	Patented	[3]
US9216972, 61	DM7AHQE	N. A.	N. A.	Patented	[4]
US9670220, 77	DMZG1HO	N. A.	N. A.	Patented	[5]
US10179791, Compound 296	DMLZBRM	N. A.	N. A.	Patented	[6]
JCXGHZCWAHCYGY-UHFFFAOYSA-N	DMER7QX	N. A.	N. A.	Patented	[3]
US9216972, 67	DMXR5SZ	N. A.	N. A.	Patented	[4]
US10166249, Example 695	DMVMNP1	N. A.	N. A.	Patented	[7]
US9181182, 40	DM3QIF4	N. A.	N. A.	Patented	[8]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sphingosine-1-phosphate receptor 3 (S1PR3)	TTDYP7I	S1PR3_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Pyridin-4-yl derivatives. US9617250.
2	Substituted bicyclic compounds. US9522888.
3	6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis. US9150519.
4	Tricyclic heterocyclic compounds. US9216972.
5	Fused heterocyclic derivatives as S1P modulators. US9670220.
6	Spiro-cyclic amine derivatives as S1P modulators. US10179791.
7	Substituted bicyclic compounds. US10166249.
8	S1P receptors modulators. US9181182.